Fibroblasts Protect Melanoma Cells from the Cytotoxic Effects of Doxorubicin

Melanoma is the most aggressive form of skin cancer and until recently, it was extremely resistant to radio-, immuno-, and chemotherapy. Despite the latest success of BRAF V600E-targeted therapies, responses are typically short lived and relapse is all but certain. Furthermore, a percentage (40%) of...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Tiago, Manoela, de Oliveira, Edson Mendes, Brohem, Carla Abdo, Pennacchi, Paula Comune, Paes, Rafael Duarte, Haga, Raquel Brandão, Campa, Ana, de Moraes Barros, Silvia Berlanga, Smalley, Keiran S., Maria-Engler, Silvya Stuchi
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Mary Ann Liebert, Inc. 2014
Konular:
Original Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4161062/
https://ncbi.nlm.nih.gov/pubmed/24548268
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/ten.tea.2013.0473
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller